Roth Capital Issues Pessimistic Forecast for MGRM Earnings

Monogram Orthopaedics Inc. (NASDAQ:MGRM) – Roth Capital decreased their Q3 2025 earnings estimates for Monogram Orthopaedics in a report issued on Tuesday, August 19th. Roth Capital analyst J. Wittes now anticipates that the company will post earnings per share of ($0.18) for the quarter, down from their prior forecast of ($0.13). The consensus estimate for Monogram Orthopaedics’ current full-year earnings is ($0.49) per share. Roth Capital also issued estimates for Monogram Orthopaedics’ Q4 2025 earnings at ($0.16) EPS, FY2025 earnings at ($0.59) EPS, Q1 2026 earnings at ($0.17) EPS, Q2 2026 earnings at ($0.18) EPS, Q3 2026 earnings at ($0.16) EPS, Q4 2026 earnings at ($0.15) EPS, FY2026 earnings at ($0.66) EPS, FY2027 earnings at ($0.52) EPS, FY2028 earnings at ($0.11) EPS and FY2029 earnings at $0.21 EPS.

Monogram Orthopaedics Price Performance

Shares of NASDAQ MGRM opened at $5.45 on Friday. The company has a market cap of $221.43 million, a PE ratio of -10.90 and a beta of 0.69. Monogram Orthopaedics has a 12 month low of $1.92 and a 12 month high of $6.02. The company has a 50-day simple moving average of $4.52 and a 200-day simple moving average of $3.29.

Monogram Orthopaedics (NASDAQ:MGRM) last issued its quarterly earnings data on Friday, August 15th. The company reported ($0.16) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.11) by ($0.05).

Institutional Investors Weigh In On Monogram Orthopaedics

Hedge funds and other institutional investors have recently modified their holdings of the company. Jane Street Group LLC bought a new position in Monogram Orthopaedics during the 4th quarter worth approximately $25,000. Wells Fargo & Company MN lifted its holdings in shares of Monogram Orthopaedics by 286.6% during the 4th quarter. Wells Fargo & Company MN now owns 11,597 shares of the company’s stock valued at $27,000 after purchasing an additional 8,597 shares during the last quarter. Crestwood Advisors Group LLC acquired a new stake in Monogram Orthopaedics during the 2nd quarter worth about $29,000. Northern Trust Corp boosted its holdings in Monogram Orthopaedics by 110.6% in the 4th quarter. Northern Trust Corp now owns 45,873 shares of the company’s stock worth $109,000 after buying an additional 24,088 shares during the last quarter. Finally, Geode Capital Management LLC increased its holdings in Monogram Orthopaedics by 7.7% in the 4th quarter. Geode Capital Management LLC now owns 226,378 shares of the company’s stock valued at $537,000 after purchasing an additional 16,234 shares during the last quarter. Institutional investors and hedge funds own 0.45% of the company’s stock.

Monogram Orthopaedics Company Profile

Monogram Orthopaedics, Inc focuses on developing a product solution architecture to enable patient-optimized orthopaedic implants. The company intends to produce and market robotic surgical equipment and related software, orthopedic implants, tissue ablation tools, navigation consumables, and other miscellaneous instrumentation for use in reconstructive joint replacement procedures.